Proffered Paper: PRECLINICAL EVALUATION OF PKMYT1 INHIBITION AS A NOVEL THERAPEUTIC OPPORTUNITY IN SMALL CELL LUNG CANCER

FedericaSpaggiari Oral Presenter Cancer Research UK Manchester InstituteUnited Kingdom